EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Salvia miltiorrhiza for Viral Myocarditis: Multi-Computational Pharmacological Exploration and Meta-Analytic Efficacy Validation

Xingxin Cao iD, Mingxue Li, Xueqian Xie, Zhun Feng, Weihua Jin, Yanyan Li, Fengmei Yang, Suqin Duan, Zhanlong He

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311753 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xingxin Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China. Hauptthemen laut MEDLINE: Salvia miltiorrhiza, Myocarditis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, Peking Union Medical College, unnan Province Applied Basic Research Special Project-General Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral myocarditis (VMC) is the predominant type of myocarditis and currently lacks specific therapies. Salvia miltiorrhiza (Danshen) injection has demonstrated beneficial effects as a supplementary VMC treatment, yet its pharmacological mechanisms are ambiguous, and its efficacy lacks robust evidence. This study aims to preliminarily address these issues through computational approaches and meta-analysis. Using network pharmacology, we identified 257 therapeutic targets, 106 hub genes, and 4 key S. miltiorrhiza ingredients implicated in VMC treatment. Integrating transcriptome data with LASSO and SVM machine learning algorithm yielded six core therapeutic targets from the hub genes—TNF, JUN, PECAM1, KDR, TIMP1, and EPAS1—which are primarily associated with anti-inflammatory activity, vascular remodeling, and fibrosis suppression. GO analysis identified the “inflammatory response” as the most prominent biological process. Concurrently, the PI3K-Akt, TNF, and HIF-1 signaling pathways—each closely associated with inflammation—appeared among the top 20 KEGG pathways. Overall, these results indicate that suppressing excessive inflammation is likely the primary pharmacological mechanism. In molecular docking, four key ingredients—dan-shexinkum D, danshenol A, cryptotanshinone, and methylrosmarinate—exhibited strong binding to the core therapeutic targets, with dan-shexinkum D showing the lowest total binding energy and stable binding confirmed by molecular dynamics simulations. The meta-analysis indicates that S. miltiorrhiza injection improves clinical outcomes and significantly reduces TNF-α, hs-CRP, CK-MB, cTnT, and H-FABP levels. This study used multiple computational approaches to explore the pharmacological mechanisms and identify key active components of S. miltiorrhiza in treating VMC, thereby establishing an evidence-based foundation and providing preliminary groundwork for subsequent clinical application and translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvia miltiorrhizaMyocarditisDrugs, Chinese HerbalMolecular Docking SimulationHumansNetwork PharmacologySignal TransductionComputational Biology

Stichwörter der Autor:innen

in silico dockingmachine learningmeta-analysismolecular dynamic simulationnetwork pharmacologysalvia miltiorrhizaviral myocarditis

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
  • College of Life Sciences, Yunnan University, Kunming 650500, China.

ORCID-Profile: Xingxin Cao

Förderung

  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities, Peking Union Medical College
  • unnan Province Applied Basic Research Special Project-General Project
  • Yunnan Province Applied Basic Research Special Project-General Project

Zitieren

APA

Cao, X., Li, M., Xie, X., Feng, Z., Jin, W., Li, Y., Yang, F., Duan, S., & He, Z. (2025). Salvia miltiorrhiza for Viral Myocarditis: Multi-Computational Pharmacological Exploration and Meta-Analytic Efficacy Validation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311753

Vancouver

Cao X, Li M, Xie X, Feng Z, Jin W, Li Y, et al. Salvia miltiorrhiza for Viral Myocarditis: Multi-Computational Pharmacological Exploration and Meta-Analytic Efficacy Validation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311753

BibTeX
@article{Cao2025,
  author = {Cao, Xingxin and Li, Mingxue and Xie, Xueqian and Feng, Zhun and Jin, Weihua and Li, Yanyan and Yang, Fengmei and Duan, Suqin and He, Zhanlong},
  title = {Salvia miltiorrhiza for Viral Myocarditis: Multi-Computational Pharmacological Exploration and Meta-Analytic Efficacy Validation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311753}
}
Kostenlos starten →